Skip to content
stock
marketcap
Discover
Markets
▾
Top gainers
Top losers
Most active
Market sectors
Heatmap
Valuation
Fundamentals
Treasury rates
Calendars
▾
Earnings calendar
IPO calendar
Ex-dividend calendar
Economic calendar
Activity
▾
Congress trades
Insider trades
Analyst upgrades & downgrades
Collections
Tools
▾
Screener
Compare
Backtester
Compound interest calculator
Dividend calculator
Position size calculator
Mortgage calculator
Tax calculator
Watchlist
Portfolio
Pricing
Get the app
⌘K
Sign in
Stocks
›
Glaukos Corporation
☆
☆
● Fresh
Latest: Aug 13, 2026
☆
Watchlist
Compare
Share
Buy GKOS
▾
Glaukos Corporation
GKOS
✓
Healthcare
Medical - Devices
NYSE
● Fresh
Latest: Aug 13, 2026
$186.82
+0.10%
$11.02B
Market cap
-47.08x
P/E ratio
193.96K
Volume (24h)
Compare
Share
Healthcare
Medical - Devices
NYSE
Overview
Forecast
Valuation
Financials
Technical
History
Dividends
Smart money
News
◆
Ask
Revenue + Forward P/E
Glaukos Corporation (GKOS) quarterly revenue and forward P/E
Forward P/E:
1219.9x
P/E
P/S
Download
Share to X
$0
331x
$59.02M
590x
$118.05M
849x
$177.07M
1107x
$236.09M
1366x
Estimates
Q4'23
Q2'24
Q4'24
Q2'25
Q4'25
Q2'26
Q4'26 (e)
Q2'27 (e)
Revenue
Revenue (est)
Forward P/E
stockmarketcap.io
Valuation
Market cap
$11.02B
Enterprise value
$9.07B
P/E ratio (TTM)
-47.08x
P/S ratio (TTM)
16.45x
P/B ratio
13.35x
EV/Sales
16.45x
EV/EBITDA
-62.97x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$507.44M
Gross profit (TTM)
$393.22M
Operating income (TTM)
$-86.73M
EBITDA (TTM)
$-146.06M
Net income (TTM)
$-187.69M
Free cash flow (TTM)
$-54.01M
Margins & returns
Gross margin
78.08%
Operating margin
-15.58%
Profit margin
-34.34%
Return on equity
-26.46%
Return on assets
-21.19%
Per-share metrics
EPS (TTM)
-$3.26
Dividend yield
0.00%
Beta
0.75
Capital structure
Cash & equivalents
$90.81M
Total debt
$139.64M
Net debt
$48.83M
Shares outstanding
58.98M
Financial health
Current ratio
4.69
Debt / equity
0.21
Debt / assets
0.16
Interest coverage
-18.71
Valuation vs peers
Share to X
Download
Company
Market cap
P/E
P/S
EV/EBITDA
Div yield
Eli Lilly and Company
LLY
$1.15T
42.41x
15.59x
34.80x
0.54%
Johnson & Johnson
JNJ
$630.20B
30.45x
6.47x
20.76x
1.99%
AbbVie Inc.
ABBV
$443.22B
127.13x
7.29x
30.82x
2.63%
UnitedHealth Group Incorporated
UNH
$365.41B
27.06x
0.85x
16.46x
2.13%
Roche Holding AG
SWX: ROP
$354.73B
23.91x
4.80x
15.14x
2.67%
Merck & Co., Inc.
MRK
$332.40B
36.82x
4.94x
19.57x
2.56%
Glaukos Corporation
GKOS
$11.02B
-47.08x
16.45x
-62.97x
-